ALGIPHARMA AS
Developing proprietary alginate technology for advanced drug delivery systems.
Översikt
- 6
- Anställda
- 6t NOK
- Omsättning
- 1992
- Grundat
Nyckelbeslutsfattare
Yngvar P. Berg
Chief Executive Officer
Fredrik Alpsten
Chief Financial Officer
Preston W. Campbell
Non-Executive Board Member
Arne Dessen
Chief Operating Officer and Chairman of the Board of Directors
+19 fler kontakter i Funnelfeedr
Beskrivning
AlgiPharma is a clinical stage biopharmaceutical company focused on leveraging its proprietary alginate technology. The company centers its efforts on developing this technology into versatile drug delivery platforms for various therapeutic agents, including nanoparticles and large molecules. Their...